Sigma-Aldrich Posts 11 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported third-quarter revenue growth of 11 percent, with organic sales up 4 percent year over year.

The St. Louis-based chemicals and research products firm reported total revenues of $626 million for the three-month period ended Sept. 30, compared to revenues of $563 million for Q3 2010. The results fell short of Wall Street estimates for revenues of $632.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.